Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects

Blocking the CD40-CD154 interaction is reported to be effective for transplantation management and autoimmune disease models in rodents and nonhuman primates. However, clinical trials with anti-CD154 mAbs were halted because of high incidence of thromboembolic complications. Thus, we generated and characterized a fully human anti-CD40 mAb ASKP1240, as an alternative to anti-CD154 mAb. In vitro ASKP1240 concentration-dependently inhibited human peripheral blood mononuclear cell proliferation induced by soluble CD154. In addition, ASKP1240 did not destabilize platelet thrombi under physiological high shear conditions while mouse anti-human CD154 mAb (mu5C8) did. And ASKP1240 itself did not activate platelet and endothelial cells. In vivo administration of ASKP1240 (1 or 10 mg/kg, intravenously) to cynomolgus monkeys, weekly for 3 weeks, significantly attenuated both delayed-type hypersensitivity and specific antibody formation evoked by tetanus toxoid. The immunosuppressive effect was well correlated with the CD40 receptor saturation. Thus, these results suggest that ASKP1240 is immunosuppressive but not prothromboembolic, and as such appears to be a promising therapeutic candidate for the management of solid organ transplant rejection and autoimmune diseases therapy.

Dependence of beam emittance on plasma electrode temperature and rf-power, and filter-field tuning with center-gapped rod-filter magnets in J-PARC rf-driven H(-) ion source

The prototype rf-driven H(-) ion-source with a nickel plated oxygen-free-copper (OFC) plasma chamber, which satisfies the Japan Proton Accelerator Research Complex (J-PARC) 2nd stage requirements of a H(-) ion beam current of 60 mA within normalized emittances of 1.5 π mm mrad both horizontally and vertically, a flat top beam duty factor of 1.25% (500 μs × 25 Hz) and a life-time of more than 50 days, was reported at the 3rd international symposium on negative ions, beams, and sources (NIBS2012). The experimental results of the J-PARC ion source with a plasma chamber made of stainless-steel, instead of nickel plated OFC used in the prototype source, are presented in this paper. By comparing these two sources, the following two important results were acquired. One was that the about 20% lower emittance was produced by the rather low plasma electrode (PE) temperature (TPE) of about 120 °C compared with the typically used TPE of about 200 °C to maximize the beam current for the plasma with the abundant cesium (Cs). The other was that by using the rod-filter magnets with a gap at each center and tuning the gap-lengths, the filter-field was optimized and the rf-power necessary to produce the J-PARC required H(-) ion beam current was reduced typically 18%. The lower rf-power also decreases the emittances.

Operation and development status of the J-PARC ion source

A cesium-free H(-) ion source driven with a LaB6 filament is being operated at the Japan Proton Accelerator Research Complex (J-PARC) without any serious trouble since the restoration from the March 2011 earthquake. The H(-) ion current from the ion source is routinely restricted approximately 19 mA for the lifetime of the filament. In order to increase the beam power at the linac beam operation (January to February 2013), the beam current from the ion source was increased to 22 mA. At this operation, the lifetime of the filament was estimated by the reduction in the filament current. According to the steep reduction in the filament current, the break of the filament was predicted. Although the filament has broken after approximately 10 h from the steep current reduction, the beam operation was restarted approximately 8 h later by the preparation for the exchange of new filament. At the study time for the 3 GeV rapid cycling synchrotron (April 2013), the ion source was operated at approximately 30 mA for 8 days. As a part of the beam current upgrade plan for the J-PARC, the front end test stand consisting of the ion source and the radio frequency quadrupole is under preparation. The RF-driven H(-) ion source developed for the J-PARC 2nd stage requirements will be tested at this test stand.

Novel morphological features in the death of MCF-7 human breast cancer cells after exposure to anticancer drugs

Cell death of human breast cancer cell line MCF-7/pDsRed2-Mito, caused by independent- or multi-administration of three anticancer drugs, cyclophosphamide [CPA], doxorubicin [DXR], and 5-fluorouracil [5-FU], was studied using fluorescence and electron microscopy. In our previous study using cell viability assays, microscopic inspection of heterochromatin condensation, a DNA fragmentation assay, and flow cytometric analyses, the death of MCF-7 cells was classified into two groups. The cell death induced by CPA or 5-FU was classified as apoptotic, while the cell death induced by DXR treatment or a mixture of all three anticancer drugs was classified as non-apoptotic. Here, we examined the morphology of the whole cell and its organelles, including the mitochondria, using electron microscopy. Mitochondria are of particular interest because they are the key organelle for the molecular apoptotic-death cascade. To monitor mitochondrial morphology, we used our previously constructed MCF-7/pDsRed2-Mito line, generated by introducing the pDsRed2-Mito vector into MCF-7 cells. The mitochondria in these cells emit red fluorescence. We found that the administration of DXR alone or of all three anticancer drugs together resulted in the clumping of the red-fluorescent materials on both sides of the round dying cells, interrupted by the nucleus. Detailed electron microscopic observation revealed that the novel morphology of the dying MCF-7 cells might be owing, not to destruction of the mitochondrial membrane, but to the tight structure of the nuclear membrane. Other anticancer drugs showed different, characteristic features in electron microscopic images, which suggested that death induced by anti-cancer drugs in the human breast cancer cell line, MCF-7, may result from any of a number of diverse processes.

An innovative high-power constant-current pulsed-arc power-supply for a high-density pulsed-arc-plasma ion-source using a LaB6-filament

An innovative high-power constant-current (CC) pulsed-arc (PA) power-supply (PS) indispensable for a high-density PA plasma ion-source using a lanthanum hexaboride (LaB(6)) filament was devised by combining a constant-voltage (CV) PA-PS, which is composed of an insulated gate bipolar transistor (IGBT) switch, a CV direct-current (dc) PS and a 270 mF capacitor with a CC-PA-PS, which is composed of an IGBT-switch, a CC-dc-PS and a 400 microH inductor, through the inductor. The hybrid-CC-PA-PS succeeded in producing a flat arc-pulse with a peak power of 56 kW (400 A x 140 V) and a duty factor of more than 1.5% (600 micros x 25 Hz) for Japan Proton Accelerator Research Complex (J-PARC) H(-) ion-source stably. It also succeeded in shortening the 99% rising-time of the arc-pulse-current to about 20 micros and tilting up or down the arc-pulse-current arbitrarily and almost linearly by changing the setting voltage of its CV-dc-PS.

Development of an H- ion source for Japan Proton Accelerator Research Complex upgrade

A cesium (Cs) free H(-) ion source driven with a lanthanum hexaboride (LaB(6)) filament was adopted as an ion source for the first stage of the Japan Proton Accelerator Research Complex (J-PARC). At present, the maximum H(-) ion current produced by the ion source is 38 mA, using which J-PARC can produce a proton beam power of 0.6 MW by accelerating it with the 181 MeV linac and the 3 GeV rapid cycling synchrotron. In order to satisfy the beam power of 1 MW required for the second stage of the J-PARC in the near future, we have to increase the ion current to more than 60 mA. Therefore, we have started to develop a Cs-seeded ion source by adding an external Cs-seeding system to a J-PARC test ion source that has a structure similar to that of the J-PARC ion source except for the fact that the plasma chamber is slightly larger. As a result, a H(-) ion current of more than 70 mA was obtained from the ion source using a tungsten filament instead of a LaB(6) filament with a low arc discharge power of 15 kW (100 V, 150 A).

Recent operation status of Japan Proton Accelerator Research Complex H- ion source

A cesium-free H(-) ion source driven with a LaB(6) filament is being operated at the Japan Proton Accelerator Research Complex for approximately three years without any serious trouble. In the beam commissioning or supply runs, the ion source has been operated in two different modes such as low current mode of 5 mA and high current mode of 30 mA. The total interruption time during the runs due to the ion source failure is approximately 50 h, which correspond to the ion source availability of 99%. After a long-term operation, the surface of the filament and the plasma electrode become discolored with dark partially. The result of surface analysis with field emission scanning electron microscope showed that most of the dark material is formed with boron. At the beam test performed in the interval of the run, we demonstrated that the H(-) current increased by miniaturizing the LaB(6) filament.

A survey of optimal filament shape in a Japan Proton Accelerator Research Complex H- ion source

Dependence of various shapes of lanthanum hexaboride (LaB(6)) filaments on H(-) ion currents (I_H(-)'s) was examined by using the first Japan Proton Accelerator Research Complex (J-PARC) test ion source. It is almost the same with the J-PARC H(-) ion source (J-PARC-IS) except for the maximum arc current (290 A instead of 400 A). An I_H(-) of 35.2 mA was extracted by using a cylindrical double-spiral LaB(6) filament with a diameter of 29.5 mm and a length of 35.5 mm, which is the same one used in J-PARC-IS. It increased to 43.4 mA with a flat triple-hairpin LaB(6) filament. The I_H(-) is considered to be increased by the enlargement of the high density plasma region near the plasma electrode aperture and the reduction of the LaB(6) filament unemission area located in the high density plasma region.

Interesting experimental results in Japan Proton Accelerator Research Complex H- ion-source development (invited)

The following interesting experimental results observed in Japan Proton Accelerator Research Complex (J-PARC) H(-) ion-source developments are reviewed. It was proven that almost all of H(-) ions were produced with surface reactions in cesium (Cs)-free J-PARC H(-) ion-sources. The world's most intense class H(-) ion current of 38 mA in Cs-free ion sources for a high-energy linac was attained by an optimal shape and high temperature of the plasma electrode (PE), usage of a lanthanum hexaboride (LaB(6)) filament, and a newly devised high-power constant-current pulsed-arc power supply indispensable for it. It was also proven that the H(-) ion current could be increased to more than 40 mA by optimizing LaB(6)-filament shape. The surface elemental analysis of the PE after operation with a LaB(6)-filament showed that it was coated by boron (B) 95.5%, lanthanum (La) 2.5%, and oxygen (O) 1.9%. The H(-) ion current decreased by about 20% when a tungsten (W) filament was used instead of a LaB(6)-filament. The H(-) ion current could not be increased by seeding cesium (Cs) if the LaB(6)-filament was used. On the other hand, it was increased to more than 70 mA with much lower arc current of 150 A if Cs was seeded when a W-filament was used.

Development and operation of a Cs-free J-PARC H(-) ion source

A cesium-free H(-) ion source driven with a LaB(6) filament was developed for the J-PARC. It was operated for the J-PARC linac beam commissioning, which was started on 20 November 2006. Eight runs of 2 or 3 week beam commissioning were done until the end of June 2007. The source was mainly operated with a duty factor of 0.8% (320 micros and 25 Hz) while providing a 5 mA beam typically. Each interval of the runs, precise optimizations, such as the filament position, and so on, are examined. At present, a H(-) beam with a current of 38 mA and a rms normalized emittance of 0.22 pi mm mrad is extracted with a duty factor of 0.8% (320 micros and 25 Hz).

Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study

PURPOSE

To investigate intraoperative visibility and long-term clinical outcome following triamcinolone acetonide (TA)-assisted pars plana vitrectomy (PPV) for proliferative vitreoretinopathy (PVR).

METHODS

A retrospective interventional noncomparative clinical study was carried out on 21 eyes from 21 patients with more than grade C2 PVR, all of whom underwent TA-assisted PPV. Two of the specimens were observed with an electron microscope. After treatment, outcome measures, including changes in best-corrected visual acuity (BCVA), intraocular pressure (IOP) elevation, corneal pathology, and occurrence of endophthalmitis, were recorded. Patient follow-up time was >36 months (mean +/-standard deviation = 47.3 +/- 6.7 months).

RESULTS

TA improved the intraoperative visualization of the epiretinal membrane (ERM), allowing it to be easily removed together with the partially internal limiting membrane (ILM) using micro forceps. The excised tissue consisted of proliferative cells and an extracellular matrix underlying the ILM. After the operation, 71.4% of the eyes had improved BCVA. Three of the eyes showed sustained IOP elevation (14.3%); two of these cases were controlled by the administration of eyedrops, while the third required filtering surgery. In two cases, an absorption delay of the TA granule on the retinal surface was observed. One eye developed corneal stromal opacity. No other severe complications occurred during the observation period.

CONCLUSIONS

TA-assisted PPV offers improved visualization during the surgical management of PVR, and allows surgeons to excise the ERM safely and effectively without the risk of serious complications.

Acoustic feedback system with digital signal processor to alert the subject and quantitative visualization of arousal reaction induced by the sound using dynamic characteristics of saccadic eye movement: a preliminary study

A new system has been developed to assess human alertness and to alert the subject with acoustic stimulation in accordance with the assessed level of alertness. Dynamic characteristics of saccadic eye movement (saccade: SC) were used to calculate an alertness index. Digital signal processor was adopted for the calculation. The system was tested through eye tracking tasks. The results indicated that the developed system could awaken the subject by feeding sound back to the subject. Also, arousal reaction induced by the sound was visualized quantitatively by analyzing values of the alertness index after the stimulation. These results indicate applicability of the system not only to awakening device for accident prevention, but also to a tool for investigating effects of the stimulation.

Relation between human alertness, velocity wave profile of saccade, and performance of visual activities

Practical method for assessing human alertness is desired for preventing traffic accidents caused by drowsiness in the drivers. We examined relation between saccade profile (PV/D), which was reported to have dependency on the alertness, and visual activities to investigate an applicability of the saccade for assessing the alertness in vision-dependent circumstances such as driving. We defined a new parameter of visual activity as "bit rate of visual perception (BRVP)", and analyzed relations of saccade velocity profile to the BRVP, relative pupil diameter, and critical fusion frequency. The results showed significant high positive correlations between PV/D, BRVP, and relative pupil diameter.

Hyperresponsiveness of bronchial but not tracheal smooth muscle in a murine model of allergic bronchial asthma

OBJECTIVE

To determine a change in airway smooth muscle contractility in a murine model of allergic asthma, the responsiveness of airway smooth muscles isolated from ovalbumin (OA)-sensitized and -challenged mice was compared with that from control animals.

METHODS

Actively sensitized mice were repeatedly challenged by ovalbumin (OA) antigen inhalation. Twenty-four h after the last antigen challenge, tracheal and bronchial smooth muscle responsiveness to acetylcholine (ACh) and endothelin-1 (ET-1) were measured. Airway microvascular leakage and histochemistry were also determined as indices of airway inflammation.

RESULTS

Both the ACh and ET-1 responsiveness of bronchial, but not tracheal, smooth muscles were significantly augmented in OA-challenged mice, whereas no significant change in the expression levels of M2, M3 and ETB receptors was observed. The Evans blue dye extravasation in the main bronchial, but not tracheal, tissue of OA-challenged mice was significantly increased as compared with that of sensitized control animals. A marked inflammatory cells infiltration was also observed in bronchial but not tracheal tissues of OA-challenged mice.

CONCLUSION

Repeated antigen challenge to sensitized mice caused a hyperresponsiveness of bronchial, but not tracheal, smooth muscle accompanied with bronchial tissue inflammation.